EAM Investors’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
NAMA
EAM Investors's TWST Position: Q3 2024 in Review
EAM Investors sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 64,764 shares — an estimated $3.19M sold.
EAM Investors first reported a position in TWST in Q3 2020 and held it in 3 quarters. The position peaked at $3.19M in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.
- EAM Investors reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
- EAM Investors sold 64,764 Twist Bioscience shares in Q3 2024, an estimated $3.19M.
- EAM Investors first reported a position in Twist Bioscience in Q3 2020 and held it in 3 quarters.
- EAM Investors's Twist Bioscience position peaked at $3.19M in Q2 2024.
- 245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.
Based on EAM Investors's 13F filing for Q3 2024, filed 13 Nov 2024.